The Areca Nut and Oral Submucosal Fibrosis: A Narrative Review
The areca nut (AN) is chewed by approximately 600 million people worldwide. Among AN chewers, ~5% develop oral submucosal fibrosis (OSF), a progressive fibrotic disorder of the oral cavity. OSF is characterized by subepithelial fibrosis and mucosal rigidity, leading to restricted mouth opening, diff...
| Published in: | Dentistry Journal |
|---|---|
| Main Authors: | Kimia Kazemi, Asmaa Fadl, Felipe F. Sperandio, Andrew Leask |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-08-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2304-6767/13/8/364 |
Similar Items
Elevation of Twist expression by arecoline contributes to the pathogenesis of oral submucous fibrosis
by: Yu-Hsien Lee, et al.
Published: (2016-05-01)
by: Yu-Hsien Lee, et al.
Published: (2016-05-01)
Cystatin C: Its role in pathogenesis of OSMF
by: P.C. Anila Namboodiripad
Published: (2014-01-01)
by: P.C. Anila Namboodiripad
Published: (2014-01-01)
A review of the systemic adverse effects of areca nut or betel nut
by: Apurva Garg, et al.
Published: (2014-01-01)
by: Apurva Garg, et al.
Published: (2014-01-01)
Simvastatin Attenuates Areca Nut Extract-Induced Subdermal Fibrosis in Mice by Targeting TGF-β Signaling Pathways
by: Chi-Hua Chang, et al.
Published: (2023-10-01)
by: Chi-Hua Chang, et al.
Published: (2023-10-01)
Brief psychotic disorder related to areca nut use: a case report
by: Sixun Li, et al.
Published: (2024-05-01)
by: Sixun Li, et al.
Published: (2024-05-01)
An in-vitro exploration of the antifibrotic activity of Naringenin: A potential therapeutic agent for oral submucous fibrosis management
by: S. Samyuktha Aarthi, et al.
Published: (2025-07-01)
by: S. Samyuktha Aarthi, et al.
Published: (2025-07-01)
Estimation and Comparison of Copper Content in Raw Areca Nuts and Commercial Areca Nut Products: Implications in Increasing Prevalence of Oral Submucous Fibrosis (OSMF)
by: PHILIPS MATHEW, et al.
Published: (2014-01-01)
by: PHILIPS MATHEW, et al.
Published: (2014-01-01)
No age predilection for a disease like OSMF. A case report of 5-year-old child
by: Pratik Kariya, MDS, et al.
Published: (2020-04-01)
by: Pratik Kariya, MDS, et al.
Published: (2020-04-01)
Prevalence of oral submucous fibrosis among habitual gutkha and areca nut chewers in Moradabad district
by: Nitin Kumar Nigam, et al.
Published: (2014-01-01)
by: Nitin Kumar Nigam, et al.
Published: (2014-01-01)
MicroRNA let-7a mitigates the progression of oral submucous fibrosis by targeting high-mobility group AT-hook 2
by: Hui-Wen Yang, et al.
Published: (2025-10-01)
by: Hui-Wen Yang, et al.
Published: (2025-10-01)
Arecoline inhibits endothelial cell growth and migration and the attachment to mononuclear cells
by: Shuei-Kuen Tseng, et al.
Published: (2014-09-01)
by: Shuei-Kuen Tseng, et al.
Published: (2014-09-01)
Effectiveness of areca nut and products containing areca nut cessation interventions: A network meta-analysis
by: Anusa Arunachalam Mohandoss, et al.
Published: (2024-07-01)
by: Anusa Arunachalam Mohandoss, et al.
Published: (2024-07-01)
The molecular mechanisms underlying arecoline-induced cardiac fibrosis in rats
by: Ku Chang-Wen, et al.
Published: (2021-11-01)
by: Ku Chang-Wen, et al.
Published: (2021-11-01)
Proliferative and morphologic characterization of buccal mucosal fibroblasts in areca nut chewers: A cell culture study
by: Deepu George Mathew, et al.
Published: (2011-01-01)
by: Deepu George Mathew, et al.
Published: (2011-01-01)
Oropharyngeal stenosis in patient with oral submucous fibrosis: a case report with 8-year follow-up
by: Maged Ali Al-Aroomi, et al.
Published: (2024-06-01)
by: Maged Ali Al-Aroomi, et al.
Published: (2024-06-01)
Head and neck squamous cell carcinoma in chronic areca nut chewing Indian women: Case series and review of literature
by: Sidramesh Shivanand Muttagi, et al.
Published: (2012-01-01)
by: Sidramesh Shivanand Muttagi, et al.
Published: (2012-01-01)
The association between betel quid use and oral potentially malignant and malignant disorders in Southeast Asian and Pacific regions: a systematic review and meta-analysis with GRADE evidence profile
by: Aula Jasim, et al.
Published: (2024-05-01)
by: Aula Jasim, et al.
Published: (2024-05-01)
Osthole mitigates the myofibroblast properties in oral submucous fibrosis by suppressing the TGF-β/smad2 signaling pathway and NCK-AS1 expression
by: Po-Yu Yang, et al.
Published: (2025-04-01)
by: Po-Yu Yang, et al.
Published: (2025-04-01)
Mast cell mediated myofibroblast differentiation responsible for progression of oral submucous fibrosis
by: Mamatha GS Reddy, et al.
Published: (2024-03-01)
by: Mamatha GS Reddy, et al.
Published: (2024-03-01)
Immunohistochemical evaluation of myofibroblasts using alpha-smooth muscle actin in oral submucous fibrosis
by: Teena Philip, et al.
Published: (2014-01-01)
by: Teena Philip, et al.
Published: (2014-01-01)
Quantification of betel quid hygroscopicity in context to saliva: A proof of concept for future studies
by: Sachin C. Sarode, et al.
Published: (2023-01-01)
by: Sachin C. Sarode, et al.
Published: (2023-01-01)
Potential Role of Host Microbiome in Areca Nut-Associated Carcinogenesis and Addiction
by: Lihui Chen, et al.
Published: (2022-11-01)
by: Lihui Chen, et al.
Published: (2022-11-01)
Evaluating Alterations of the Oral Microbiome and Its Link to Oral Cancer among Betel Quid Chewers: Prospecting Reversal through Probiotic Intervention
by: Prerna Diwan, et al.
Published: (2023-07-01)
by: Prerna Diwan, et al.
Published: (2023-07-01)
Relationship of clinical features with candidal carriage in oral submucous fibrosis patients: A case-control study
by: Anju Redhu, et al.
Published: (2021-01-01)
by: Anju Redhu, et al.
Published: (2021-01-01)
Adipose-derived stem cell exosomes attenuates myofibroblast transformation via inhibiting autophagy through TGF-β/Smad2 axis in oral submucosal fibrosis
by: Jinhao Xu, et al.
Published: (2024-12-01)
by: Jinhao Xu, et al.
Published: (2024-12-01)
Assessment of Effects of Areca Nut in the Development of Oral Sub-mucous Fibrosis amongst Nursing Students
by: Erum Aftab, et al.
Published: (2019-12-01)
by: Erum Aftab, et al.
Published: (2019-12-01)
Oral submucous fibrosis at pediatric age, now time to think: Series of two cases
by: Vinay K Gupta, et al.
Published: (2013-01-01)
by: Vinay K Gupta, et al.
Published: (2013-01-01)
Potential of Areca catechu Nut Extract for Osteoarthritis: Study on Rat Model
by: Humaryanto Humaryanto, et al.
Published: (2023-06-01)
by: Humaryanto Humaryanto, et al.
Published: (2023-06-01)
Epigallocatechin-3-gallate inhibits the collagen accumulation of oral submucous fibrosis induced by arecoline
by: Ge Gao, et al.
Published: (2025-01-01)
by: Ge Gao, et al.
Published: (2025-01-01)
Systematic Review of Roles of Arecoline and Arecoline <i>N</i>-Oxide in Oral Cancer and Strategies to Block Carcinogenesis
by: Albert Min-Shan Ko, et al.
Published: (2023-04-01)
by: Albert Min-Shan Ko, et al.
Published: (2023-04-01)
Jiawei Danxuan Koukang Alleviates Arecoline Induced Oral Mucosal Lesions: Network Pharmacology and the Combined Ultra-High Performance Liquid Chromatography (UPLC) and Mass Spectrometry (MS)
by: Zhou L, et al.
Published: (2023-10-01)
by: Zhou L, et al.
Published: (2023-10-01)
Regulation of hypoxia-inducible factor-1α in human buccal mucosal fibroblasts stimulated with arecoline
by: Yung-Chuan Ho, et al.
Published: (2017-06-01)
by: Yung-Chuan Ho, et al.
Published: (2017-06-01)
Association of Areca Nut Chewing With Risk of Erectile Dysfunction
by: Yung-Jui Huang, PhD, et al.
Published: (2017-09-01)
by: Yung-Jui Huang, PhD, et al.
Published: (2017-09-01)
Oral submucous fibrosis: a contemporary narrative review with a proposed inter-professional approach for an early diagnosis and clinical management
by: Naman R. Rao, et al.
Published: (2020-01-01)
by: Naman R. Rao, et al.
Published: (2020-01-01)
Regulation of myofibroblast dedifferentiation in pulmonary fibrosis
by: Xuetao Ju, et al.
Published: (2024-07-01)
by: Xuetao Ju, et al.
Published: (2024-07-01)
Advances in macrophage-myofibroblast transformation in fibrotic diseases
by: Jia-Qi Ban, et al.
Published: (2024-10-01)
by: Jia-Qi Ban, et al.
Published: (2024-10-01)
Loricrin expression and its implication in oral submucous fibrosis, hyperkeratosis and normal mucosa with association to habits – An immunohistochemical study
by: Nithya S, et al.
Published: (2019-07-01)
by: Nithya S, et al.
Published: (2019-07-01)
Iatrogenic cushing’s syndrome post intralesional triamcinolone acetonide in oral submucous fibrosis: 2 case reports
by: Kuenga Choden, et al.
Published: (2023-10-01)
by: Kuenga Choden, et al.
Published: (2023-10-01)
Knowledge, attitude, and practices of areca nut and betel quid chewing among the adult population – A questionnaire-based cross-sectional study
by: Juhi Gupta, et al.
Published: (2024-04-01)
by: Juhi Gupta, et al.
Published: (2024-04-01)
Pharmaceutical Assessment Suggests Locomotion Hyperactivity in Zebrafish Triggered by Arecoline Might Be Associated with Multiple Muscarinic Acetylcholine Receptors Activation
by: Petrus Siregar, et al.
Published: (2021-04-01)
by: Petrus Siregar, et al.
Published: (2021-04-01)
Similar Items
-
Elevation of Twist expression by arecoline contributes to the pathogenesis of oral submucous fibrosis
by: Yu-Hsien Lee, et al.
Published: (2016-05-01) -
Cystatin C: Its role in pathogenesis of OSMF
by: P.C. Anila Namboodiripad
Published: (2014-01-01) -
A review of the systemic adverse effects of areca nut or betel nut
by: Apurva Garg, et al.
Published: (2014-01-01) -
Simvastatin Attenuates Areca Nut Extract-Induced Subdermal Fibrosis in Mice by Targeting TGF-β Signaling Pathways
by: Chi-Hua Chang, et al.
Published: (2023-10-01) -
Brief psychotic disorder related to areca nut use: a case report
by: Sixun Li, et al.
Published: (2024-05-01)
